Clobetasol Propionate

CAS 25122-46-7 13 current records 5 historicalSmall Molecule

Who holds supplier records for Clobetasol Propionate? 13 organisations hold a current record for Clobetasol Propionate: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), Italy (2), Netherlands (2), Spain (1) and 3 other countries (3); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Clobetasol Propionate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/clobetasol-propionate

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Clobetasol Propionate expires 9 May 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Clobetasol Propionate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Clobetasol Propionate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Clobetasol Propionate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HENAN LIHUA PHARMACEUTICAL CO., LTD. AnyangCN
CEP 2020-395 - Rev 01
Clobetasol propionate
Apr 2026—
SYMBIOTEC PHARMALAB LIMITED IndoreIN
CEP 2007-263 - Rev 03
Clobetasol propionate, Micronised, non-micronised
Apr 2026Inspected Mar 2026
Germany
AVIK PHARMACEUTICAL LIMITED VapiIN
CEP 2009-315 - Rev 03
Clobetasol propionate
Dec 2025—
FARMABIOS S.p.A Gropello CairoliIT
CEP 2011-135 - Rev 04
Clobetasol propionate, Micronised, non-micronised
Nov 2025Inspected Jul 2026
Italy
CURIA SPAIN S.A.U. BoecilloES
CEP 2011-095 - Rev 02
Clobetasol propionate
Apr 2025Inspected Feb 2026
Spain
TAPI NL B.V. AmsterdamNL
CEP 2007-066 - Rev 06
Clobetasol propionate, Micronised
Mar 2025—
JIANGSU GRAND XIANLE PHARMACEUTICAL CO., LTD. YanchengCN
CEP 2023-058 - Rev 00
Clobetasol propionate
Nov 2024—
GlaxoSmithKline Research & Development Limited LondonGB
CEP 2011-034 - Rev 04
Clobetasol propionate, Montrose site
Oct 2024—
NEWCHEM S.p.A. MilanoIT
CEP 2017-294 - Rev 04
Clobetasol propionate, Micronised
Aug 2024—
SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. PeraiMY
R1-CEP 2009-221 - Rev 00
Clobetasol propionate
Oct 2015—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Clobetasol Propionate are no longer active. These show a past filing, not current supply.

Show all 5 historical records
  • GLAXOSMITHKLINE LLC
    Inactive DMF 25444 · filed Dec 2012
  • India · Inactive DMF 22650 · filed Dec 2008
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 18202 · filed Mar 2005
  • Portugal · Inactive DMF 9781 · filed Jul 1992
  • CESQUISA SA
    Inactive DMF 8096 · filed Apr 1989

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (57 listed products contain Clobetasol Propionate). The latest listed patent expires 9 May 2036. The latest listed exclusivity runs to 4 Mar 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Clobetasol Propionate is a synthetic corticosteroid used primarily in dermatology to reduce inflammation and itching associated with various skin conditions. It is highly potent and is often prescribed for short-term use only due to potential systemic side effects.

Chemical identity

IUPAC name
[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
Canonical SMILES
CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl
InChIKey
CBGUOGMQLZIXBE-XGQKBEPLSA-N
Synonyms
Temovate API, cci 4725, cci-4725, clobetasol 17-propionate, clobex, cormax, dermovate, embeline, gr 2/925, gr-2/925, impeklo, impoyz

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists

Therapeutic areas

Dermatology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Clobetasol Propionate?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Clobetasol Propionate: CURIA SPAIN SAU (Spain), Farmabios S.p.A. (Italy), NEWCHEM SPA (Italy), SYMBIOTEC PHARMALAB PRIVATE LTD (India), SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (Malaysia), TAPI NL BV (Netherlands), ENVEE DRUGS PVT LTD (India) and HALCYON LABS PRIVATE LTD (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Clobetasol Propionate Drug Master Files are active?

CURIA SPAIN SAU (DMF 26191), Farmabios S.p.A. (DMF 8336), NEWCHEM SPA (DMF 22226, 42892), SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 20821), SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (DMF 24015), TAPI NL BV (DMF 6814), ENVEE DRUGS PVT LTD (DMF 30752) and HALCYON LABS PRIVATE LTD (DMF 21216) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Clobetasol Propionate records mean?

5 organisations have only inactive Type II DMFs for Clobetasol Propionate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Clobetasol Propionate have a European Certificate of Suitability?

Yes. 10 organisations hold a valid CEP for Clobetasol Propionate on the EDQM register, including HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang (CN), SYMBIOTEC PHARMALAB LIMITED Indore (IN), AVIK PHARMACEUTICAL LIMITED Vapi (IN), FARMABIOS S.p.A Gropello Cairoli (IT), CURIA SPAIN S.A.U. Boecillo (ES) and TAPI NL B.V. Amsterdam (NL) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Clobetasol Propionate?

Yes. The latest patent listed for an approved US product containing Clobetasol Propionate expires 9 May 2036, across 57 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Clobetasol Propionate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Clobetasol Propionate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.